{"name":"Engeneic Pty Limited","slug":"engeneic-pty-limited","ticker":"","exchange":"","domain":"engeneicpty.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPZmdCUkY3MWJRYUQxdktxY2RKSUd0S0pheGxPLUNBRTdyX3J0czlmMnZ6aDQxZE9sY2RVWWdtWXFuc0pwRzktZ213QUVVWjk5MHlVMTR4VVV5QTkxelREdmdUYWdGamR1amxoOUFpRXdhMVhkTkJCYkcyOVFvQmFNY3ZlbHFxMVZoeGtLSEZVcng2eTFDU0RWUkNKUGpJSDZON3laYXRzV200THNKT3JjSg?oc=5","date":"2025-07-21","type":"pipeline","source":"forbes.com.au","summary":"Why investors have put $100m behind Australian biotech’s ‘Trojan horse’ for cancer - forbes.com.au","headline":"Why investors have put $100m behind Australian biotech’s ‘Trojan horse’ for cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxNcjgyeklfRVZxR09JU2pmWjV5VVJmUEpyNjJRbVBJamUxNEM0cW0tSk1TeHhPZml1V3NDRjZScE1UajhYd09Oa0p5bUh4X2RFcUNZN1N3S29KYlBVUHJYcVg5SEJycUFfdm0yMXBqMVJYVlJZdUtsYjNoMzlRckxUZWc2OWRqeWZGaE1aYXNZaXBBczRKSGZsUHQ0U1pneDhaUjNOQ1lhaDFDTU5HSlV0SXZhdnZNdDltaEkxZ0dlV1h6N3IxRVBIX2kwcGhEdkVUal9yOHJrNUxWX0pOWmdKWHlqaW5lMG5Bc093dW93ZldTLWhERXJrSXRreUFVRFpjT3dUT0JVRFR5S01pU1Fsa0l3eTZBWVctN05mUFdtNjlYZGFHQy1HQ3kwUXEtX01ZM3c?oc=5","date":"2025-05-12","type":"trial","source":"GlobeNewswire","summary":"EnGeneIC launches groundbreaking new Australian trial for - GlobeNewswire","headline":"EnGeneIC launches groundbreaking new Australian trial for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQbk1tc3dTdnpCbnJYR1I0RXRkT2NXdmlBdzdDdl8yTHpabHNUVEdETGloRWppOUQyNXotNFNlU3BwZF9XMG5SdXpac09ITUh6OXl4N0I1eFh4Rk9fVVRpWnhOZnhQNWFFa2VhWnp2bG1sVlVNOG1QYjNiYnhiTVBzSWZFMW9QZ2xwQk5aZ1k0d3JaT2VnUU92LXIyUlk0RFdsZ3Y4SFdXX2gxS1NWOEY5RmxDdHFJYTNxajJ3Wmg3YjRCamZtTWVWaWNzdEI1V09R?oc=5","date":"2024-09-25","type":"deal","source":"BioPharma APAC","summary":"BioCina Partners with EnGeneIC to Accelerate Manufacturing of Cutting-Edge Cancer Treatment - BioPharma APAC","headline":"BioCina Partners with EnGeneIC to Accelerate Manufacturing of Cutting-Edge Cancer Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOclVVVUhaNmRQODdHS2lsaXlIdDJ5d3JUckJkZm4zamNLSk1kZ0lLUWdUdkxlRU0tcmxFMnpGWXAwSTM4b0ZOekZZZ0ZGSVFjVlQ1b0hSb2hSc2VMZmlBYVBieDZYNGlxa1NMbDRjU3o5RklCalNMVy15aDM3UXg1Z3UzckNjMHZGc296REJKSENlcXQ3eHE4M3QySmJ5dEJiMGJIU2tILU5LVXhpcmlwcWV3THYtY3ItVmV3bUo4Zm9vMk9nOUJ6YjBzcG5WSWRKUjdnaVBlbHRNSE0?oc=5","date":"2024-06-07","type":"deal","source":"BioPharma APAC","summary":"EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia - BioPharma APAC","headline":"EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPVkNRVjYzNmJOZDRvYXpBeU1id1BRRFpIYTZEQnYzOHJwd0tPcDctckJwLXQtbk5MUUhvcmJsZW1BQS1oM1BKeTJGSFhsZy1pTlFIc3JtWFREbWNXal8tVE9XdHZzemVYdWVPREJ5Tmt0SzdGakdzeEhUWmpTZGdrZFlWMkEtMmZ3TWwxVWlhdlhQb0ZLam1TQ2R2Wnh0WFVjeTRXaVowVVN4ZXhxaTh3ZVh6LW5PSXBsMWlwMmtxdzAydVdDZUJiVUdXTnM3M0pDZHZnWFpIZ1dvVlk1OUJVdjJhRGEzSVhINHY4cDQtM2xTTm9UU1E5T1l6TnA?oc=5","date":"2016-10-04","type":"pipeline","source":"BioSpace","summary":"EnGeneIC Pty Ltd's Joint-CEO And Co-Founder, Jennifer Macdiarmid, Ph.D., Recognized In Innovation Category In The Australian Financial Review And Westpac 100 Women Of Influence Awards For 2016 - BioSp","headline":"EnGeneIC Pty Ltd's Joint-CEO And Co-Founder, Jennifer Macdiarmid, Ph.D., Recognized In Innovation Category In The Austra","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}